LifeVantage EBIT Margin
The EBIT Margin (Operating Margin) of LifeVantage (LFVN) as of Jul 24, 2026 is 5.34 %. In the previous year, EBIT Margin (Operating Margin) was 2.16 % — a change of 146.65% (higher).
Get this data via API
Financial Data API
EBIT Margin
5.34 %
YoY
146.65%
Last updated:
EBIT Margin (Operating Margin) of LifeVantage is 2026 5.34 % . EBIT Margin (Operating Margin) of LifeVantage was 2025 2.16 % . It decreases by 146.65% higher compared to the previous year.
LifeVantage's operating (EBIT) margin stands at 5.3%, down from 8.0% several years earlier.
Access this data via the Eulerpool API
LifeVantage Stock analysis
What does LifeVantage do? LifeVantage Corp is a US-based company that was founded in 2003. It specializes in biohacking products and offers a wide range of products for improving health and well-being. The company is known for its use of innovative technologies in product manufacturing, ensuring that each product is of the highest quality.
LifeVantage is headquartered in Salt Lake City, Utah, and has branch offices in the US, Mexico, Hong Kong, Thailand, Japan, and Australia. Its mission is to help people improve their quality of life and optimize their health. The company offers an extensive range of products under the motto of "biohacking."
Some of the key products offered by LifeVantage are nutritional supplements that utilize nutrients, antioxidants, and plant extracts to strengthen the immune system and support the body's detoxification process. The company's products are categorized into various categories, ranging from skincare products to nutritional supplements.
One of LifeVantage's most well-known products is Protandim, a nutritional supplement that contains eight essential nutrients and antioxidants, which help reduce inflammation in the body. Protandim has been developed by LifeVantage and has proven to be an effective remedy against inflammation and oxidative damage in the body.
The company also offers other products, such as TrueScience Anti-Aging Cream, which is based on the use of nutrients and antioxidants for skin rejuvenation. This innovative cream is one of the most effective ways to revitalize the appearance of the skin on the face, décolleté, hands, and other body parts.
Another significant product from LifeVantage is PhysIQ, a specialized diet and weight loss plan that is based on a complex formula for weight control and natural metabolism boosting. The plan includes specific nutritional supplements and supports training to promote weight loss.
LifeVantage's business model is based on a network marketing concept. This means that the company does not rely on expensive marketing or advertising but instead builds a representative structure that sells the products directly through referrals and word-of-mouth. Representatives are encouraged to recruit new customers and earn commissions based on the products sold.
LifeVantage's products are distributed worldwide and have established themselves as effective and safe methods for supporting physical well-being. The company emphasizes scientific research and works closely with experts to ensure that its products are always up to date with technology and research.
Overall, LifeVantage is an innovative and reliable company that specializes in the development and manufacturing of high-quality biohacking products, helping customers achieve optimal health and well-being. The network marketing concept also makes it easy for beginners to earn a stable income by directly selling these innovative products to customers. LifeVantage is one of the most popular companies on Eulerpool.
Frequently Asked Questions about LifeVantage stock
EBIT Margin (Operating Margin) of LifeVantage is 5.34 % in 2026.
Access this data via the Eulerpool API
Margins — LifeVantage
All Key Metrics — LifeVantage
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth